Ian F. Smith
Chairman
Solid Biosciences Inc. (SLDB)Board Member
Solid Biosciences Inc. (SLDB)Board Member
Stoke Therapeutics, Inc. (STOK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Current
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Stoke Therapeutics, Inc. (STOK) | Chief Executive Officer | $170,625 | $27,031,655 |
| 2019 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Former EVP & Chief Operating Officer and Former Interim Chief Financial Officer | $75,192 | $1,451,840 |
| 2018 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Former EVP & Chief Operating Officer and Former Interim Chief Financial Officer | $850,000 | $4,626,134 |
| 2017 | Vertex Pharmaceuticals Inc / Ma (VRTX) | Former EVP & Chief Operating Officer and Former Interim Chief Financial Officer | $848,077 | $5,936,236 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.